Inactive Instrument

Calendar Nektar Therapeutics Nasdaq

Equities

Chart calendar Nektar Therapeutics

7d.oWIa9ZxWQ-8Q9XqvW-DhiCrJ86Y81mLD8HiGNEBRXaI._lIpgOUhOZokog_GDLir8h_9lcxj50-qsQHgUBIwbsb3KCOd_T51lySwMw~bd16ae0d0a03e084facadca0b5b738b7

Upcoming events on Nektar Therapeutics

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on Nektar Therapeutics

2024-03-05 02:10 pm TD Cowen Health Care Conference
2024-03-04 05:00 pm Q4 2023 Earnings Call
2024-03-04 04:15 pm Q4 2023 Earnings Release
2024-01-10 08:15 pm JPMorgan Healthcare Conference
2023-11-07 05:00 pm Q3 2023 Earnings Call
2023-11-07 04:15 pm Q3 2023 Earnings Release
2023-10-13 08:30 am European Academy of Dermatology and Venereology Conference - Abstract #6685
2023-10-10 European Academy of Dermatology and Venereology Conference - Abstract #6218
2023-09-13 11:00 am Investor & Analyst Meeting
2023-08-08 05:00 pm Q2 2023 Earnings Call
2023-08-08 04:15 pm Q2 2023 Earnings Release
2023-06-14 04:20 pm Goldman Sachs Global Healthcare Conference
2023-06-08 05:00 pm Annual General Meeting
2023-05-09 05:00 pm Q1 2023 Earnings Call
2023-05-09 04:15 pm Q1 2023 Earnings Release
2023-02-28 05:15 pm Q4 2022 Earnings Release
2023-02-23 05:00 pm REZPEG Phase 2 Study Results Call
2023-01-11 11:15 am JP Morgan Healthcare Conference
2022-12-12 08:30 am Investor Meeting
2022-12-09 American Society of Hematology Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
115
108
6.09%
153
159
-3.97%
102
102
-0.03%
92,1
91,5
0.66%
90,1
84,3
6.88%

67,5

EBITDA
Million USD
Released
Forecast
Spread
-427
-440
2.99%
-411
-430
4.52%
-432
-451
4.23%
-363
-398
8.74%
-256
-250
-2.46%

-134

EBIT
Million USD
Released
Forecast
Spread
-440
-449
2.1%
-425
-432
1.5%
-446
-470
5.08%
-376
-401
6.13%
-264
-269
2.07%

-172

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-440
-449
2.05%
-444
-443
-0.3%
-523
-530
1.21%
-365
-401
9.01%
-276
-275
-0.57%

-168

Net income
Million USD
Released
Forecast
Spread
-441
-447
1.33%
-444
-443
-0.42%
-524
-530
1.2%
-368
-403
8.56%
-276
-275
-0.53%

-168

EPS
USD
Released
Forecast
Spread
-2,52
-2,52
0.07%
-2,49
-2,49
0.06%
-2,86
-2,90
1.53%
-1,97
-2,15
8.45%
-1,45
-1,45
-0.21%

-0,85

Announcement Date27/02/2025/02/2128/02/2228/02/2304/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
25,0
25,2
-0.65%
24,8
24,9
-0.26%
21,6
22,7
-5.1%
23,6
22,6
4.5%
22,0
22,2
-0.86%
21,6
19,4
11.16%
20,5
21,8
-6.08%
24,1
21,3
13.28%
23,9
21,4
11.78%

15,3


15,3


15,3


15,3

EBITDA
Million USD
Released
Forecast
Spread
-109
-128
14.55%
-113
-138
18.24%
-149
-200
25.3%
-51,6
-75,0
31.17%
-49,3
-68,0
27.52%
-42,7
-53,0
19.42%






-31,9
-26,0
-22.53%












EBIT
Million USD
Released
Forecast
Spread
-113
-133
15.07%
-117
-125
6.46%
-153
-172
11.29%
-54,3
-73,6
26.26%
-52,5
-72,1
27.2%
-45,0
-39,0
-15.33%
-50,6
-45,1
-12.08%
-44,9
-33,8
-32.81%
-33,5
-39,2
14.6%

-38,9


-38,9


-39,1


-40,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-146
-149
2.32%
-90,3
-135
32.98%
-159
-182
12.43%
-59,2
-84,6
29.98%
-56,5
-81,0
30.16%
-137
-45,5
-201.11%
-51,2
-58,6
12.73%
-45,9
-38,8
-18.34%
-42,1
-43,4
3.07%

-40,1


-41,9


-43,6


-44,9

Net income
Million USD
Released
Forecast
Spread
-146
-147
1.24%
-90,4
-129
30.16%
-159
-187
14.9%
-59,0
-86,0
31.36%
-59,7
-84,1
29.07%
-137
-48,0
-185.38%
-51,1
-55,5
7.93%
-45,8
-39,5
-15.95%
-42,1
-43,7
3.69%

-40,1


-41,9


-43,6


-44,9

EPS
USD
Released
Forecast
Spread
-0,79
-0,81
2.14%
-0,49
-0,70
29.63%
-0,85
-1,00
15.17%
-0,31
-0,46
32.2%
-0,32
-0,45
28.34%
-0,73
-0,26
-185.98%
-0,27
-0,28
4%
-0,24
-0,20
-20.86%
-0,22
-0,21
-3.51%

-0,20


-0,20


-0,20


-0,20

Announcement Date28/02/2205/05/2204/08/2203/11/2228/02/2309/05/2308/08/2307/11/2304/03/24----